Semnur Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $0 | $0 |
| FY2023 | — | $-38.1M | $204.5K |
| FY2024 | — | $-42.8M | $12.0K |
| FY2025 | — | $-20.8M | $20.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $0 | $0 |
| FY2023 | — | $-38.1M | $204.5K |
| FY2024 | — | $-42.8M | $12.0K |
| FY2025 | — | $-20.8M | $20.0K |